Skip to content

Drug interactions

Tiotropium-olodaterol + Vorinostat

Severity: Moderate

Tiotropium-olodaterol and Vorinostat: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vorinostat has been associated with QT prolongation, and olodaterol may add to this effect through beta2-agonist cardiac stimulation and potassium lowering. The combination may increase the risk of ventricular arrhythmias, especially with electrolyte disturbance.

What this interaction means in plain words

Tiotropium-olodaterol and Vorinostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Tiotropium-olodaterol belongs to Respiratory; Vorinostat belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation with beta2-agonist-related hypokalemia.

What to do

Obtain baseline and periodic ECG and monitor potassium and magnesium, correcting deficits promptly. Avoid adding further QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tiotropium-olodaterol and Vorinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tiotropium-olodaterol with Vorinostat?

MediHelp rates the interaction as moderate. Tiotropium-olodaterol and Vorinostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Vorinostat has been associated with QT prolongation, and olodaterol may add to this effect through beta2-agonist cardiac stimulation and potassium lowering. The combination may increase the risk of ventricular arrhythmias, especially with electrolyte disturbance.

How serious is the interaction between Tiotropium-olodaterol and Vorinostat?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain baseline and periodic ECG and monitor potassium and magnesium, correcting deficits promptly. Avoid adding further QT-prolonging drugs.

What other medicines interact with Tiotropium-olodaterol?

MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in